318 related articles for article (PubMed ID: 22503544)
1. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.
Schuck RN; Theken KN; Edin ML; Caughey M; Bass A; Ellis K; Tran B; Steele S; Simmons BP; Lih FB; Tomer KB; Wu MC; Hinderliter AL; Stouffer GA; Zeldin DC; Lee CR
Atherosclerosis; 2013 Apr; 227(2):442-8. PubMed ID: 23466098
[TBL] [Abstract][Full Text] [Related]
3. Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.
Theken KN; Deng Y; Schuck RN; Oni-Orisan A; Miller TM; Kannon MA; Poloyac SM; Lee CR
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E500-9. PubMed ID: 22185841
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study.
Oni-Orisan A; Edin ML; Lee JA; Wells MA; Christensen ES; Vendrov KC; Lih FB; Tomer KB; Bai X; Taylor JM; Stouffer GA; Zeldin DC; Lee CR
J Lipid Res; 2016 Jan; 57(1):109-19. PubMed ID: 26555503
[TBL] [Abstract][Full Text] [Related]
6. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
8. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
[TBL] [Abstract][Full Text] [Related]
10. CYP Genetic Variants, CYP Metabolite Levels, and Neurologic Deterioration in Acute Ischemic Stroke in Chinese Population.
Yi X; Lin J; Wang C; Zhou Q
J Stroke Cerebrovasc Dis; 2017 May; 26(5):969-978. PubMed ID: 27916259
[TBL] [Abstract][Full Text] [Related]
11. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.
Deng Y; Theken KN; Lee CR
J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972
[TBL] [Abstract][Full Text] [Related]
13. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease.
Minuz P; Jiang H; Fava C; Turolo L; Tacconelli S; Ricci M; Patrignani P; Morganti A; Lechi A; McGiff JC
Hypertension; 2008 May; 51(5):1379-85. PubMed ID: 18378855
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
15. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
16. Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE).
Pickens CA; Sordillo LM; Zhang C; Fenton JI
Metabolism; 2017 May; 70():177-191. PubMed ID: 28403941
[TBL] [Abstract][Full Text] [Related]
17. Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.
Theken KN; Deng Y; Kannon MA; Miller TM; Poloyac SM; Lee CR
Drug Metab Dispos; 2011 Jan; 39(1):22-9. PubMed ID: 20947618
[TBL] [Abstract][Full Text] [Related]
18. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
19. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
20. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
